158 related articles for article (PubMed ID: 23782142)
1. New pharmaceutical treatment of gastric MALT lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib.
Nakamura M; Takahashi T; Matsui H; Takahashi S; Murayama SY; Suzuki H; Tsuchimoto K
Curr Pharm Des; 2014; 20(7):1097-103. PubMed ID: 23782142
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by Helicobacter heilmannii infection.
Nakamura M; Matsui H; Takahashi T; Ogawa S; Tamura R; Murayama SY; Takahashi S; Tsuchimoto K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S1-6. PubMed ID: 20586849
[TBL] [Abstract][Full Text] [Related]
3. Increased apoptosis and angiogenesis in gastric low-grade mucosa-associated lymphoid tissue-type lymphoma by Helicobacter heilmannii infection in C57/BL6 mice.
Nishikawa K; Nakamura M; Takahashi S; Matsui H; Murayama SY; Matsumoto T; Yamada H; Tsuchimoto K
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):268-72. PubMed ID: 17488330
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory alteration in low-grade gastric mucosa-associated lymphoma by Helicobacter heilmannii infection: its relation to vascular endothelial growth factor and cyclooxygenase-2.
Nakamura M; Takahashi S; Matsui H; Murayama SY; Aikawa C; Sekiya Y; Nishikawa K; Matsumoto T; Yamada H; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S157-60. PubMed ID: 19120890
[TBL] [Abstract][Full Text] [Related]
5. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
6. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
7. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
8. Interaction of VEGF to gastric low grade MALT lymphoma by Helicobacter heilmannii infection in C57/BL/6 mice.
Nakamura M; Matsui H; Murayama SY; Matsumoto T; Yamada H; Takahashi S; Tsuchimoto K
Inflammopharmacology; 2007 Jun; 15(3):115-8. PubMed ID: 19847951
[TBL] [Abstract][Full Text] [Related]
9. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter suis Infection in Mouse Induced not Only Gastric, but Hepatic and Pulmonary MALT Lymphoma: Relation to Substance P.
Nakamura M; Kodama Y; Øverby A; Takahashi S; Ohshima K; Suzuki H; Murayama SY; Matsui H
Curr Pharm Des; 2020; 26(25):3039-3045. PubMed ID: 32329683
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of Helicobacter pylori-negative gastric MALT lymphoma with rituximab.
Chaudhary N; Ozer H; Huard D; Lightfoot S; Mesiya S
Dig Dis Sci; 2006 Apr; 51(4):775-8. PubMed ID: 16615002
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma.
Takigawa H; Masaki S; Naito T; Yuge R; Urabe Y; Tanaka S; Sentani K; Matsuo T; Matsuo K; Chayama K; Kitadai Y
Cancer Med; 2019 Aug; 8(9):4370-4379. PubMed ID: 31210418
[TBL] [Abstract][Full Text] [Related]
14. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.
O'Rourke JL; Dixon MF; Jack A; Enno A; Lee A
J Pathol; 2004 Aug; 203(4):896-903. PubMed ID: 15258991
[TBL] [Abstract][Full Text] [Related]
15. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
16. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.
Morgner A; Thiede C; Bayerdörffer E; Alpen B; Wündisch T; Neubauer A; Stolte M
Curr Gastroenterol Rep; 2001 Dec; 3(6):516-22. PubMed ID: 11696290
[TBL] [Abstract][Full Text] [Related]
18. Alteration of angiogenesis in Helicobacter heilmannii-induced mucosa-associated lymphoid tissue lymphoma: interaction with c-Met and hepatocyte growth factor.
Nakamura M; Takahashi T; Matsui H; Baniwa Y; Takahashi S; Murayama SY; Serizawa H; Suzuki H; Hibi T
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():70-6. PubMed ID: 25521737
[TBL] [Abstract][Full Text] [Related]
19. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
